Aiful Corp
TSE:8515
Aiful Corp
TSE:8515
Price:
331
JPY
0.91%
Market Closed
Market Cap:
160.4B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Aiful Corp
331
+3 (+0.91%)
| 52 Week Range |
289
532
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Aiful Corp
Balance Sheet
Balance Sheet Decomposition
Aiful Corp
Aiful Corp
| Current Assets | 1.2T |
| Cash & Short-Term Investments | 51.8B |
| Receivables | 884.6B |
| Other Current Assets | 301.9B |
| Non-Current Assets | 92.2B |
| PP&E | 16.7B |
| Intangibles | 28.2B |
| Other Non-Current Assets | 47.3B |
| Current Liabilities | 742B |
| Accounts Payable | 53.8B |
| Short-Term Debt | 125.1B |
| Other Current Liabilities | 563.2B |
| Non-Current Liabilities | 385.8B |
| Long-Term Debt | 363.1B |
| Other Non-Current Liabilities | 22.7B |
Balance Sheet
Aiful Corp
Aiful Corp
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
52 590
|
39 910
|
33 644
|
29 327
|
36 112
|
43 524
|
40 950
|
44 448
|
43 251
|
56 917
|
|
| Cash Equivalents |
52 590
|
39 910
|
33 644
|
29 327
|
36 112
|
43 524
|
40 950
|
44 448
|
43 251
|
56 917
|
|
| Short-Term Investments |
688
|
546
|
694
|
940
|
1 209
|
1 451
|
1 701
|
2 312
|
2 540
|
2 989
|
|
| Total Receivables |
329 219
|
367 327
|
409 926
|
475 339
|
520 978
|
577 152
|
571 780
|
615 374
|
707 918
|
822 822
|
|
| Accounts Receivables |
41 569
|
51 781
|
57 298
|
62 633
|
63 193
|
60 192
|
52 267
|
62 579
|
86 704
|
105 305
|
|
| Other Receivables |
287 650
|
315 546
|
352 628
|
412 706
|
457 785
|
516 960
|
519 513
|
552 795
|
621 214
|
717 517
|
|
| Inventory |
0
|
0
|
7 305
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
126 880
|
128 238
|
130 031
|
142 447
|
159 707
|
191 595
|
195 281
|
218 667
|
256 239
|
307 851
|
|
| Total Current Assets |
509 377
|
536 021
|
581 600
|
648 053
|
718 006
|
813 722
|
809 712
|
880 801
|
1 009 948
|
1 190 579
|
|
| PP&E Net |
17 678
|
17 690
|
17 664
|
18 133
|
16 758
|
19 698
|
17 765
|
16 908
|
16 238
|
17 092
|
|
| PP&E Gross |
17 678
|
17 690
|
17 664
|
18 133
|
16 758
|
19 698
|
17 765
|
16 908
|
16 238
|
17 092
|
|
| Accumulated Depreciation |
22 029
|
22 767
|
23 221
|
24 007
|
24 929
|
26 469
|
25 526
|
26 672
|
27 779
|
27 203
|
|
| Intangible Assets |
2 575
|
3 161
|
3 113
|
3 198
|
3 297
|
4 285
|
5 306
|
6 737
|
8 392
|
14 349
|
|
| Note Receivable |
33 983
|
0
|
29 323
|
27 787
|
26 981
|
23 609
|
22 082
|
22 567
|
18 167
|
15 131
|
|
| Long-Term Investments |
5 530
|
5 419
|
7 524
|
4 052
|
5 643
|
5 960
|
7 714
|
6 571
|
10 978
|
12 086
|
|
| Other Long-Term Assets |
8 820
|
26 723
|
22 573
|
18 578
|
10 098
|
6 767
|
775
|
2 058
|
6 762
|
17 137
|
|
| Total Assets |
560 323
N/A
|
567 514
+1%
|
616 651
+9%
|
682 645
+11%
|
760 587
+11%
|
860 507
+13%
|
863 354
+0%
|
935 642
+8%
|
1 070 485
+14%
|
1 266 374
+18%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
10 158
|
12 209
|
15 620
|
16 196
|
21 076
|
37 156
|
38 265
|
40 919
|
43 066
|
68 069
|
|
| Accrued Liabilities |
902
|
112 548
|
913
|
991
|
1 320
|
1 356
|
1 397
|
1 377
|
1 600
|
1 672
|
|
| Short-Term Debt |
51 460
|
67 990
|
73 610
|
83 325
|
86 562
|
103 119
|
100 750
|
81 343
|
83 316
|
102 586
|
|
| Current Portion of Long-Term Debt |
32 713
|
22 439
|
34 924
|
55 082
|
106 387
|
143 075
|
162 273
|
202 864
|
184 905
|
264 124
|
|
| Other Current Liabilities |
127 636
|
21 965
|
149 806
|
151 746
|
164 932
|
184 675
|
196 911
|
222 754
|
260 025
|
311 147
|
|
| Total Current Liabilities |
222 869
|
237 151
|
274 873
|
307 340
|
380 277
|
469 381
|
499 596
|
549 257
|
572 912
|
747 598
|
|
| Long-Term Debt |
142 782
|
159 101
|
192 323
|
228 375
|
226 424
|
233 714
|
197 846
|
198 818
|
294 781
|
298 900
|
|
| Deferred Income Tax |
225
|
281
|
252
|
334
|
7
|
49
|
75
|
7
|
0
|
107
|
|
| Minority Interest |
0
|
0
|
0
|
4 957
|
3 741
|
2 914
|
2 136
|
2 626
|
3 520
|
3 502
|
|
| Other Liabilities |
96 972
|
66 731
|
37 554
|
27 189
|
25 863
|
28 432
|
18 145
|
31 034
|
23 199
|
18 357
|
|
| Total Liabilities |
462 848
N/A
|
463 264
+0%
|
505 002
+9%
|
568 195
+13%
|
636 312
+12%
|
734 490
+15%
|
717 798
-2%
|
781 742
+9%
|
894 412
+14%
|
1 068 464
+19%
|
|
| Equity | |||||||||||
| Common Stock |
143 401
|
143 415
|
143 454
|
143 454
|
143 454
|
94 028
|
94 028
|
94 028
|
94 028
|
94 028
|
|
| Retained Earnings |
207 414
|
49 773
|
42 422
|
39 974
|
30 255
|
20 232
|
38 669
|
47 560
|
69 419
|
90 345
|
|
| Additional Paid In Capital |
164 469
|
13 914
|
13 953
|
13 948
|
13 948
|
13 948
|
13 948
|
14 017
|
14 017
|
14 017
|
|
| Unrealized Security Profit/Loss |
128
|
0
|
225
|
184
|
23
|
459
|
1 705
|
1 098
|
1 123
|
1 283
|
|
| Treasury Stock |
3 110
|
0
|
3 110
|
3 110
|
3 110
|
3 110
|
3 110
|
3 110
|
3 110
|
2 655
|
|
| Other Equity |
1
|
1
|
1
|
316
|
261
|
460
|
316
|
307
|
596
|
892
|
|
| Total Equity |
97 475
N/A
|
104 250
+7%
|
111 649
+7%
|
114 450
+3%
|
124 275
+9%
|
126 017
+1%
|
145 556
+16%
|
153 900
+6%
|
176 073
+14%
|
197 910
+12%
|
|
| Total Liabilities & Equity |
560 323
N/A
|
567 514
+1%
|
616 651
+9%
|
682 645
+11%
|
760 587
+11%
|
860 507
+13%
|
863 354
+0%
|
935 642
+8%
|
1 070 485
+14%
|
1 266 374
+18%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
483
|
483
|
484
|
484
|
484
|
484
|
484
|
484
|
484
|
484
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
